- US12595314utility2026Antibody Specific for GPC3 and Methods of Use Thereof0 cites
- US12544338utility2026Solid or Semisolid Lipid Based Dosage Form Stabilization Through Curing and Addition of Low HLB Surfactant(s)0 cites
- US12527745utility2026Pharmaceutical Dosage Form for an Emulsion of Simethicone and Loperamide0 cites
- US12458699utility2025Formulation for Oral Delivery of Proteins, Peptides and Small Molecules with Poor Permeability0 cites
- US12409143utility2025Softgel Capsules and a Method for Preparing the Softgel Capsules0 cites
- US12357541utility2025Two Part Rotary Die Encapsulation System0 cites
- US12324857utility2025Apparatus and Process for Secondary Encapsulation of Solid Inclusions Using the Rotary Die Process0 cites
- US12296021utility2025Antibody Conjugates and Methods of Making and Using the Same0 cites
- US12241877utility2025Analytical Method0 cites
- US12187745utility2025Camptothecine Antibody-drug Conjugates and Methods of Use Thereof0 cites
- US12187810utility2025Glycoside Dual-cleavage Linkers for Antibody-drug Conjugates0 cites
- US12161605utility2024Method to Relieve Stress in Capsule Shells to Reduce Propensity to Break0 cites
- US12133922utility2024Abuse Resistant Capsule0 cites
- US12102689utility2024Anti-cd22 Antibody-maytansine Conjugates and Methods of Use Thereof0 cites
- US12090232utility2024Enteric Softgel Capsules0 cites
- US12018308utility2024Activated Formylglycine-generating Enzymes and Methods of Producing and Using the Same0 cites
- US11980668utility2024Sulfatase-cleavable Linkers for Antibody-drug Conjugates0 cites
- US11980691utility2024Enteric Softgel Capsules0 cites
- US11970546utility2024Antibody Specific for Mucin-1 and Methods of Use Thereof0 cites
- US11857637utility2024Anti-cd25 Antibody-maytansine Conjugates and Methods of Use Thereof0 cites
Page 1 of 2Next →